Maravai Lifesciences Holdings (MRVI) Minority Interest (2020 - 2026)

Maravai Lifesciences Holdings' Minority Interest history runs 7 years deep, the most recent figure standing at $157.5 million for Q1 2026.

• On a quarterly basis, Minority Interest fell 31.41% year-over-year to $157.5 million in Q1 2026; TTM through Mar 2026 was $157.5 million, a 31.41% decrease from a year earlier, with the FY2025 full-year figure at $160.3 million, down 36.36% from the prior year.
• Minority Interest retreated to $157.5 million in Q1 2026 per MRVI's latest filing, from $160.3 million in the prior quarter.
• Across five years, Minority Interest topped out at $379.1 million in Q1 2023 and bottomed at $157.5 million in Q1 2026.
• The 5-year median for Minority Interest is $317.2 million (2022), against an average of $291.1 million.
• Across the five-year window, Minority Interest surged 172.6% in 2022 and sank 40.16% in 2025, its largest moves.
• Year by year, Minority Interest stood at $360.0 million in 2022, then increased by 3.64% to $373.1 million in 2023, then tumbled by 32.49% to $251.9 million in 2024, then sank by 36.36% to $160.3 million in 2025, then fell by 1.75% to $157.5 million in 2026.
• Per Business Quant, the three latest MRVI Minority Interest figures stand at $157.5 million (Q1 2026), $160.3 million (Q4 2025), and $186.4 million (Q3 2025).